Impact of Different Definitions of Airflow Limitation on the Prevalence of Chronic Obstructive Pulmonary Disease in the General Population

Background: Recent surveys report a surprisingly high prevalence of chronic obstructive pulmonary disease (COPD) worldwide. However, there is evidence that the application of a fixed ratio of forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) may result in a relevant misclassification of airflow limitation. Objectives: The definition of airflow limitation does have a significant impact on its prevalence. Methods: Individual values of lung volumes were assessed in comparison to a reference population by applying either a fixed ratio below 0.7 or the fifth percentile of FEV1 in relation to FVC. Based on a large-scale population-based survey, reference equations for lung volumes were derived by quantile regression analysis based on 1,809 subjects aged 25–85 years. Both functional definitions were applied to calculate the prevalence of airflow limitation. Results: The prevalence of airflow limitation was significantly higher when applying the fifth percentile compared to the fixed ratio of 0.7 for all age groups and both sexes (all 6.7 vs. 1.9%; women 6.7 vs. 1.3%; men 6.6 vs. 2.6%). Almost 26% of the subjects with airflow limitation complained of dyspnea, whereas COPD had not been previously diagnosed by a physician in 87%. Conclusion: The definition of airflow limitation has a major impact on the observed prevalence rates.

[1]  H Völzke,et al.  Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study , 2008, European Respiratory Journal.

[2]  A. Buist,et al.  [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study]. , 2008, Deutsche medizinische Wochenschrift.

[3]  M. Ezzati,et al.  Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study , 2008, The Lancet.

[4]  J Stocks,et al.  Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction , 2008, Thorax.

[5]  N. Probst-Hensch,et al.  Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD , 2008, Thorax.

[6]  M. Decramer,et al.  Bronchodilator responsiveness in patients with COPD , 2008, European Respiratory Journal.

[7]  D. Mannino,et al.  Reversing concepts on COPD irreversibility , 2008, European Respiratory Journal.

[8]  C. Schindler,et al.  Reference equations for lung function screening of healthy never-smoking adults aged 18–80 years , 2008, European Respiratory Journal.

[9]  J. Hankinson,et al.  Definition of COPD: based on evidence or opinion? , 2008, European Respiratory Journal.

[10]  N. Roche,et al.  The Effect of an Information Leaflet upon Knowledge and Awareness of COPD in Potential Sufferers , 2008, Respiration.

[11]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[12]  A. Buist,et al.  Prevalence of COPD and tobacco smoking in Malopolska region--results from the BOLD study in Poland. , 2007, Polskie Archiwum Medycyny Wewnetrznej.

[13]  C. Jiang,et al.  Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study , 2007, The Lancet.

[14]  J. E. Hansen,et al.  Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. , 2007, Chest.

[15]  F. Vega-Redondo.  Complex Social Networks: Econometric Society Monographs , 2007 .

[16]  Michael J. Allison,et al.  COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. , 2007, Chest.

[17]  H. Völzke,et al.  Rauchen: Regionale Unterschiede in Deutschland , 2006 .

[18]  A. Gulsvik,et al.  Post-bronchodilator spirometry reference values in adults and implications for disease management. , 2006, American journal of respiratory and critical care medicine.

[19]  H. Völzke,et al.  Urban-rural disparities in smoking behaviour in Germany , 2006, BMC public health.

[20]  U. Ackermann-Liebrich,et al.  Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study , 2006, Thorax.

[21]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[22]  A. Gulsvik,et al.  Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study , 2005, Thorax.

[23]  U. John,et al.  Study of Health in Pomerania (SHIP): A health examination survey in an east German region: Objectives and design , 2005, Sozial- und Präventivmedizin.

[24]  A. Buist,et al.  The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. , 2005, COPD.

[25]  F Neukirch,et al.  An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages , 2004, Thorax.

[26]  D. Mannino,et al.  Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination , 2003, Journal of internal medicine.

[27]  M. Kogevinas,et al.  Smoking and occupation from the European Community Respiratory Health Survey , 2003, Occupational and environmental medicine.

[28]  A. Buist,et al.  Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers , 2002, European Respiratory Journal.

[29]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[30]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[31]  J. Roca,et al.  Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[32]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[33]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[34]  R M Gardner,et al.  Performance evaluation of contemporary spirometers. , 1990, Chest.

[35]  P. Quanjer.  Predicted values: how should we use them? , 1988, Thorax.

[36]  Buist As.  Standardization of spirometry. , 1987 .

[37]  Standardization of spirometry--1987 update. Statement of the American Thoracic Society. , 1987, The American review of respiratory disease.

[38]  Standardization of spirometry--1987 update. Official statement of American Thoracic Society. , 1987, Respiratory care.

[39]  W. J. Dixon,et al.  Introduction to Statistical Analysis , 1951 .